Co-Diagnostics Inc. (NASDAQ:CODX) went down by -5.08% from its latest closing price compared to the recent 1-year high of $30.99. The company’s stock price has collected 4.91% of gains in the last five trading sessions. Press Release reported on 01/07/21 that Co-Diagnostics to Present at H.C. Wainwright BioConnect 2021 Virtual Conference
Get the hottest stocks to trade every day before the market opens 100% free. Click here now.
Is It Worth Investing in Co-Diagnostics Inc. (NASDAQ :CODX) Right Now?
Co-Diagnostics Inc. (NASDAQ:CODX) scored a price-to-earnings ratio above its average ratio, recording 11.69 x from its present earnings ratio. Plus, the 36-month beta value for CODX is at -1.77. Opinions of the stock are interesting as 2 analysts out of 2 who provided ratings for Co-Diagnostics Inc. declared the stock was a “buy,” while 0 rated the stock as “overweight,” 0 rated it as “hold,” and 0 as “sell.”
The average price from analysts is $31.00. CODX currently public float of 26.43M and currently shorts hold a 25.76% ratio of that float. Today, the average trading volume of CODX was 1.86M shares.
CODX’s Market Performance
CODX stocks went up by 4.91% for the week, with a monthly jump of 3.05% and a quarterly performance of -27.46%, while its annual performance rate touched 788.17%. The volatility ratio for the week stands at 7.15% while the volatility levels for the past 30 days are set at 6.86% for Co-Diagnostics Inc.. The simple moving average for the period of the last 20 days is -0.85% for CODX stocks with a simple moving average of -28.65% for the last 200 days.
Analysts’ Opinion of CODX
H.C. Wainwright, on the other hand, stated in their research note that they expect to see CODX reach a price target of $35, previously predicting the price at $20. The rating they have provided for CODX stocks is “Buy” according to the report published on May 18th, 2020.
H.C. Wainwright gave a rating of “Buy” to CODX, setting the target price at $20 in the report published on March 09th of the previous year.
CODX Trading at -9.79% from the 50-Day Moving Average
After a stumble in the market that brought CODX to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -66.25% of loss for the given period.
Volatility was left at 6.86%, however, over the last 30 days, the volatility rate increased by 7.15%Over the last 50 days, in opposition, the stock is trading -23.06% lower at present.
During the last 5 trading sessions, CODX rose by +4.91%, which changed the moving average for the period of 200-days by +11.28% in comparison to the 20-day moving average, which settled at $10.55. In addition, Co-Diagnostics Inc. saw 12.47% in overturn over a single year, with a tendency to cut further gains.
Insider Trading
Reports are indicating that there were more than several insider trading activities at CODX starting from SERBIN RICHARD S, who sale 17,000 shares at the price of $10.10 back on Dec 14. After this action, SERBIN RICHARD S now owns 0 shares of Co-Diagnostics Inc., valued at $171,700 using the latest closing price.
Durenard Eugene, the Director of Co-Diagnostics Inc., sale 10,000 shares at $10.15 during a trade that took place back on Dec 10, which means that Durenard Eugene is holding 0 shares at $101,500 based on the most recent closing price.
Stock Fundamentals for CODX
Current profitability levels for the company are sitting at:
- -2741.61 for the present operating margin
- +17.04 for the gross margin
The net margin for Co-Diagnostics Inc. stands at -2882.00. The total capital return value is set at -455.64, while invested capital returns managed to touch -1,826.40. Equity return is now at value 102.10, with 96.20 for asset returns.
Get the hottest stocks to trade every day before the market opens 100% free. Click here now.
The receivables turnover for the company is 2.97 and the total asset turnover is 0.11. The liquidity ratio also appears to be rather interesting for investors as it stands at 4.83.
